Paul Van Schil

27PUBLICATIONS
40CO-AUTHORS
Women's studies (incl. girls' studies)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jan 06, 2026
Gender differences in Myasthenia Gravis in a neuromuscular reference center in Belgium.

Alicia Alonso-Jiménez, Willem De Ridder, Paul Van Schil

|Nov 27, 2025
Lung Ischemia-Reperfusion Injury in Lung Transplant Surgery: Where Do We Stand?

Lawek Berzenji, Jeroen M H Hendriks, Stijn E Verleden

|Apr 16, 2025
Is PET-CT able to predict histology and aggressiveness of thymic epithelial tumours?

Apostolos C Agrafiotis, Paul E Van Schil

|Mar 15, 2025
Are there any limits to perform segmentectomy for non-peripheral early-stage non-small-cell lung cancer?

Apostolos C Agrafiotis, Paul E Van Schil

|Dec 09, 2023
An Overview of the Use of Anti-Angiogenic Agents in the Treatment of Thymic Epithelial Tumors.

Apostolos C Agrafiotis, Lawek Berzenji, Stien Koyen

|Sep 09, 2023
Minimally Invasive Surgery in Non-Small Cell Lung Cancer: Where Do We Stand?

Lawek Berzenji, Wen Wen, Stijn Verleden

Pageof 5